Octreotide treatment in a neonate with non-chylous pleural effusion
pdf

How to Cite

Kalay, S. ., Oztekin, . O. ., Tezel, G. ., Demir, B. E. ., Akcakuş, M. ., & Oygur, . N. . (2026). Octreotide treatment in a neonate with non-chylous pleural effusion. African Journal of Paediatric Surgery, 10(4), 374–376. https://doi.org/10.67481/ajps.v10i4.618

Abstract

Fetal pleural effusion is a rare condition. While it may regress spontaneously, it may also continue up to the post-natal period. This condition may be treated by thoracentesis, thoracoabdominal shunt application and pleurodesis in the intrauterine period while thoracentesis or tube thoracostomy may be used in the post-natal period. In cases where the fluid is defined to represent chylothorax, octreotide, a somatostatin analogue, may be administered for treatment. In this case report, we discussed the outcomes of treatment with octreotide administered in a neonatal case under follow-up due to fetal pleural effusion and with non chylous ascites detected in the post-natal period.

https://doi.org/10.67481/ajps.v10i4.618
pdf